A Randomized Phase 2 Study Exploring the Role of Bevacizumab and a Chemotherapy-Free Approach in HER2-Positive Metastatic Breast Cancer: The HAT Study (BOOG 2008-2003), a Dutch Breast Cancer Research Group Trial

Jan Drooger; H van Tinteren; SM de Groot; AJ ten Tije; H de Graaf; JEA Portielje; Agnes Jager; A Honkoop; SC Linn; JR Kroep; FLG Erdkamp; P Hamberg; A L T Imholz; Q C van Rossum-Schornagel; JB Heijns; AE van Leeuwen-Stok; Stefan Sleijfer

doi:10.1002/cncr.30141

A Randomized Phase 2 Study Exploring the Role of Bevacizumab and a Chemotherapy-Free Approach in HER2-Positive Metastatic Breast Cancer: The HAT Study (BOOG 2008-2003), a Dutch Breast Cancer Research Group Trial

Jan Drooger, H van Tinteren, SM de Groot, AJ ten Tije, H de Graaf, JEA Portielje, Agnes Jager, A Honkoop, SC Linn, JR Kroep, FLG Erdkamp, P Hamberg, A L T Imholz, Q C van Rossum-Schornagel, JB Heijns, AE van Leeuwen-Stok, Stefan Sleijfer

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

8 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2961-2970
Number of pages	10
Journal	Cancer
Volume	122
Issue number	19
DOIs	https://doi.org/10.1002/cncr.30141
Publication status	Published - 2016

Research programs

EMC MM-03-86-01
EMC MM-03-86-08

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/cncr.30141

Cite this

Drooger, J., van Tinteren, H., de Groot, SM., ten Tije, AJ., de Graaf, H., Portielje, JEA., Jager, A., Honkoop, A., Linn, SC., Kroep, JR., Erdkamp, FLG., Hamberg, P., Imholz, A. L. T., van Rossum-Schornagel, Q. C., Heijns, JB., van Leeuwen-Stok, AE., & Sleijfer, S. (2016). A Randomized Phase 2 Study Exploring the Role of Bevacizumab and a Chemotherapy-Free Approach in HER2-Positive Metastatic Breast Cancer: The HAT Study (BOOG 2008-2003), a Dutch Breast Cancer Research Group Trial. Cancer, 122(19), 2961-2970. https://doi.org/10.1002/cncr.30141

@article{21186b7788d7472e9a05ba5bc8c8441c,

title = "A Randomized Phase 2 Study Exploring the Role of Bevacizumab and a Chemotherapy-Free Approach in HER2-Positive Metastatic Breast Cancer: The HAT Study (BOOG 2008-2003), a Dutch Breast Cancer Research Group Trial",

author = "Jan Drooger and {van Tinteren}, H and {de Groot}, SM and {ten Tije}, AJ and {de Graaf}, H and JEA Portielje and Agnes Jager and A Honkoop and SC Linn and JR Kroep and FLG Erdkamp and P Hamberg and Imholz, {A L T} and {van Rossum-Schornagel}, {Q C} and JB Heijns and {van Leeuwen-Stok}, AE and Stefan Sleijfer",

year = "2016",

doi = "10.1002/cncr.30141",

language = "Undefined/Unknown",

volume = "122",

pages = "2961--2970",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley & Sons Inc.",

number = "19",

}

Drooger, J, van Tinteren, H, de Groot, SM, ten Tije, AJ, de Graaf, H, Portielje, JEA, Jager, A, Honkoop, A, Linn, SC, Kroep, JR, Erdkamp, FLG, Hamberg, P, Imholz, ALT, van Rossum-Schornagel, QC, Heijns, JB, van Leeuwen-Stok, AE & Sleijfer, S 2016, 'A Randomized Phase 2 Study Exploring the Role of Bevacizumab and a Chemotherapy-Free Approach in HER2-Positive Metastatic Breast Cancer: The HAT Study (BOOG 2008-2003), a Dutch Breast Cancer Research Group Trial', Cancer, vol. 122, no. 19, pp. 2961-2970. https://doi.org/10.1002/cncr.30141

A Randomized Phase 2 Study Exploring the Role of Bevacizumab and a Chemotherapy-Free Approach in HER2-Positive Metastatic Breast Cancer: The HAT Study (BOOG 2008-2003), a Dutch Breast Cancer Research Group Trial. / Drooger, Jan; van Tinteren, H; de Groot, SM et al.
In: Cancer, Vol. 122, No. 19, 2016, p. 2961-2970.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - A Randomized Phase 2 Study Exploring the Role of Bevacizumab and a Chemotherapy-Free Approach in HER2-Positive Metastatic Breast Cancer: The HAT Study (BOOG 2008-2003), a Dutch Breast Cancer Research Group Trial

AU - Drooger, Jan

AU - van Tinteren, H

AU - de Groot, SM

AU - ten Tije, AJ

AU - de Graaf, H

AU - Portielje, JEA

AU - Jager, Agnes

AU - Honkoop, A

AU - Linn, SC

AU - Kroep, JR

AU - Erdkamp, FLG

AU - Hamberg, P

AU - Imholz, A L T

AU - van Rossum-Schornagel, Q C

AU - Heijns, JB

AU - van Leeuwen-Stok, AE

AU - Sleijfer, Stefan

PY - 2016

Y1 - 2016

U2 - 10.1002/cncr.30141

DO - 10.1002/cncr.30141

M3 - Article

C2 - 27315546

SN - 0008-543X

VL - 122

SP - 2961

EP - 2970

JO - Cancer

JF - Cancer

IS - 19

ER -